Natixis Ionis Pharmaceuticals Inc Transaction History

Natixis

$17.4 Billion
Q2 2024

A detailed history of Natixis transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Natixis holds 163 shares of IONS stock, worth $6,472. This represents 0.0% of its overall portfolio holdings.

Number of Shares

163

Previous 1,961 91.69%

Holding current value

$6,472

Previous $85,000 91.76%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$36.45 - $47.7 $65,537 - $85,764	-1,798 Reduced 91.69%	163 $7,000
Q1 2024 May 13, 2024	SELL	$42.03 - $53.55 $38,541 - $49,105	-917 Reduced 31.86%	1,961 $85,000
Q4 2023 Feb 13, 2024	BUY	$43.39 - $51.63 $124,876 - $148,591	2,878 New	2,878 $145,000
Q4 2022 Feb 24, 2023	BUY	$37.12 - $46.52 $965,119 - $1.21 Million	26,000 Added 19.45%	159,678 $6.03 Million
Q4 2022 Feb 13, 2023	SELL	$37.12 - $46.52 $14,959 - $18,747	-403 Reduced 0.3%	133,678 $5.05 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $4.9 Million - $6.52 Million	134,081 New	134,081 $5.94 Million
Q1 2022 May 13, 2022	SELL	$29.88 - $37.04 $8.99 Million - $11.1 Million	-300,797 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $7.7 Million - $10.6 Million	300,797 New	300,797 $9.15 Million
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $286,096 - $345,891	-8,530 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $99,164 - $135,654	2,871 Added 50.73%	8,530 $340,000
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $76,177 - $114,293	1,792 Added 46.34%	5,659 $254,000
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $3.99 Million - $5.31 Million	-88,089 Reduced 95.79%	3,867 $219,000
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $3.97 Million - $5.27 Million	83,746 Added 1020.05%	91,956 $4.36 Million
Q2 2020 Aug 13, 2020	SELL	$46.85 - $61.05 $4.3 Million - $5.6 Million	-91,681 Reduced 91.78%	8,210 $484,000
Q2 2019 Aug 13, 2019	BUY	$62.09 - $86.14 $4.71 Million - $6.54 Million	75,880 Added 316.02%	99,891 $6.42 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $1.27 Million - $1.95 Million	24,011 New	24,011 $1.92 Million
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $490,980 - $614,179	-12,114 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $533,985 - $666,875	12,114 New	12,114 $534,000

Others Institutions Holding IONS

# of Institutions

389

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account